#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	13468	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2465	670.0	1	SNP	n	C1184T	0	.	.	1184	1184	C	1628	1628	C	804	C,G	803,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22814	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3968	715.0	0	.	n	.	0	T695C	SNP	695	695	T	1240	1240	C	772	C,T,G	768,1,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22814	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3968	715.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1882	1882	A	923	A,T,G	921,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22814	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3968	715.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2516	2516	C	836	C,T,A	834,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22814	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3968	715.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2590	2590	A	780	A,G,C	776,3,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22814	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3968	715.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3142	3142	C	818	C,T	814,3	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2068	folP	855	855	100.0	folP.l15.c4.ctg.1	1996	128.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1232	1234	AGC	213;212;212	A;G;C,T	213;212;211,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4576	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3963	143.9	1	SNP	p	S91F	1	.	.	271	273	TTC	865	867	TTC	175;174;174	T;T;C,T	175;174;173,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4576	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3963	143.9	1	SNP	p	D95G	1	.	.	283	285	GGC	877	879	GGC	178;177;177	G;G;C,G	178;177;176,1	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4576	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3963	143.9	1	SNP	p	G95N	0	.	.	283	285	GGC	877	879	GGC	178;177;177	G;G;C,G	178;177;176,1	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1702	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1791	118.0	1	SNP	p	G45D	0	.	.	133	135	GGC	764	766	GGC	200;203;206	G;G;C	200;203;206	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	948	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c30.ctg.1	1445	81.7	0	.	n	.	0	A197.	DEL	197	197	A	775	775	A	186	A	186	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4548	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	165.6	1	SNP	p	D86N	0	.	.	256	258	GAC	835	837	GAC	163;165;165	G;A;C,G	163;165;164,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4548	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	165.6	1	SNP	p	S87R	1	.	.	259	261	CGT	838	840	CGT	166;166;164	C;G,C;T	166;165,1;164	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4548	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	165.6	1	SNP	p	R87I	0	.	.	259	261	CGT	838	840	CGT	166;166;164	C;G,C;T	166;165,1;164	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4548	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	165.6	1	SNP	p	R87W	0	.	.	259	261	CGT	838	840	CGT	166;166;164	C;G,C;T	166;165,1;164	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4548	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3415	165.6	1	SNP	p	S88P	0	.	.	262	264	TCC	841	843	TCC	163;164;166	T;C,A;C	163;163,1;166	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3900	parE	1986	1986	100.0	parE.l15.c17.ctg.1	3026	160.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1743	1745	GGC	219;217;216	G,T;G;C,A	218,1;217;215,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1524	1526	GCA	208;208;207	G;C;A,G	208;208;206,1	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1527	1529	ATC	206;207;208	A;T;C	206;207;208	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1539	1541	GTG	212;214;220	G;T,C;G,A	212;212,2;218,2	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1539	1541	GTG	212;214;220	G;T,C;G,A	212;212,2;218,2	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2043	2045	ACC	210;209;211	A;C;C	210;209;211	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2097	2099	GCG	201;199;197	G;C,A;G	201;198,1;197	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2097	2099	GCG	201;199;197	G;C,A;G	201;198,1;197	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2220	2222	AGC	196;198;198	A,G;G;C,G	195,1;198;197,1	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2229	2231	GGC	204;205;204	G,C,A;G;C	202,1,1;205;204	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3554	penA	1752	1752	100.0	penA.l15.c4.ctg.1	3009	147.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2247	2249	CCG	197;198;197	C,G;C,G;G,T	195,2;197,1;196,1	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5052	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3567	176.4	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1845	1847	CCG	183;183;182	C,A;C,A;G,A	182,1;182,1;180,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2138	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2348	113.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	807	807	C	162	C	162	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	100	94.0	porB1a.l6.c17.ctg.2	174	46.3	0	.	p	.	0	M18T	NONSYN	52	54	ATG	125	127	ACG	52;48;43	A;C;G	52;48;43	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	100	94.0	porB1a.l6.c17.ctg.2	174	46.3	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	167	169	CAA	12;10;10	C;A;A	12;10;10	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	16;20;22	T;T;A	16;20;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	46;46;46	C;A;T	46;46;46	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	46;46;46	A;G;T	46;46;46	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	46;46;46	T;A;C,G	46;46;45,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	R307A	NONSYN	919	921	AGA	161	163	GCA	1;1;1	G;C;A	1;1;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	T311A	NONSYN	931	933	ACA	173	175	GCA	2;2;2	G;C;A	2;2;2	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	E312D	NONSYN	934	936	GAA	176	178	GAC	2;2;3	G;A;C	2;2;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	F314I	NONSYN	940	942	TTC	182	184	ATC	3;3;3	A;T;C	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	A316S	NONSYN	946	948	GCG	188	190	TCG	3;3;3	T;C;G	3;3;3	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	V318A	NONSYN	952	954	GTC	194	196	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	G319S	NONSYN	955	957	GGC	197	199	AGC	4;4;4	A;G;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	G320A	NONSYN	958	960	GGT	200	202	GCC	4;4;4	G;C;C	4;4;4	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	252	porB1a	984	226	90.27	porB1a.l6.c17.ctg.4	467	19.9	0	.	p	.	0	G322V	NONSYN	964	966	GGT	206	208	GTT	5;5;5	G;T;T	5;5;5	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	0	.	p	.	0	N38E	NONSYN	112	114	AAT	661	663	GAA	238;239;238	G,T;A,T;A	237,1;238,1;238	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	0	.	p	.	0	T119A	NONSYN	355	357	ACC	904	906	GCC	195;192;192	G,A;C;C	194,1;192;192	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	0	.	p	.	0	N134D	NONSYN	400	402	AAT	949	951	GAT	218;221;222	G;A;T,G	218;221;221,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	0	.	p	.	0	P175S	NONSYN	523	525	CCA	1072	1074	TCA	233;234;235	T;C,A;A	233;233,1;235	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1201	1203	GTC	247;249;250	G;T;C	247;249;250	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1531	1533	GCA	228;229;230	G;C;A,T	227;229;229,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	1	SNP	p	G120K	1	.	.	358	360	AAG	907	909	AAG	195;194;197	A,G;A;G,T	194,1;194;196,1	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	1	SNP	p	D121N	0	.	.	361	363	GAC	910	912	GAC	197;197;195	G,T;A;C,A	196,1;197;194,1	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2710	porB1b	1047	1047	99.24	porB1b.l6.c17.ctg.1	1977	170.2	1	SNP	p	A121D	1	.	.	361	363	GAC	910	912	GAC	197;197;195	G,T;A;C,A	196,1;197;194,1	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9076	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5350	211.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1298	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1417	113.5	1	SNP	p	V57M	1	.	.	169	171	ATG	710	712	ATG	220;222;219	A;T;G	220;222;219	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
